Arkolith/Insider Trading/ICPT/Form 4

Rosa-Bjorkeson Dagmar

DirectorINTERCEPT PHARMACEUTICALS, INC. (ICPT) · full profile →Form 4 · filed Nov 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 8, 2023Tender(U)15K$19.00$281K0
Nov 8, 2023Disposed to issuer(D)12K$19.00$221K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 8, 2023Disposed to issuer(D)18K——0
Nov 8, 2023Disposed to issuer(D)13K——0
Nov 8, 2023Disposed to issuer(D)13K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-117104) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML